Actively Recruiting

Phase 4
Age: 18Years - 65Years
All Genders
NCT06414395

The Effects of Different Loading Doses of Dexmedetomidine on The Bispectral Index-Guided Propofol Sedation in Patients Undergoing Advanced Upper Gastrointestinal Endoscopic Procedures: A Randomized Control Study

Led by Theodor Bilharz Research Institute · Updated on 2024-05-16

52

Participants Needed

1

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Propofol is currently the most common drug used but has drawbacks like narrow therapeutic window and potential complications. Dexmedetomidine is an attractive alternative due to its unique properties like minimal respiratory depression. Studies are ongoing to find the optimal use of dexmedetomidine for these procedures. A combination of propofol and dexmedetomidine might be ideal, but the best balance between the two drugs needs further investigation.

CONDITIONS

Official Title

The Effects of Different Loading Doses of Dexmedetomidine on The Bispectral Index-Guided Propofol Sedation in Patients Undergoing Advanced Upper Gastrointestinal Endoscopic Procedures: A Randomized Control Study

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 to 65 years
  • Both sexes
  • American Society of Anesthesiologists (ASA) physical status I or II
  • Body Mass Index (BMI) less than 35
Not Eligible

You will not qualify if you...

  • Patients who refuse to participate
  • ASA physical status III or IV
  • BMI greater than 35
  • Patients at high risk of aspiration, such as those with gastric outlet obstruction
  • Allergy to any study medications
  • Diabetes
  • Use of cardioactive drugs such as beta blockers, calcium channel blockers, or inhaled B2 bronchodilators
  • Presence of pacemakers or heart rate below 50 beats per minute
  • Pregnant women
  • Habitual drug abusers
  • Patients who required intubation during the procedure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Theodor Bilharz Research Institute

Cairo, Giza Governorate, Egypt, 12411

Actively Recruiting

Loading map...

Research Team

S

Sameh M. Elaidy, Msc.

CONTACT

N

Nabawya Kamel, Proffessor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here